Placing the values and preferences of people most affected by TB at the center of screening and testing: an approach for reaching the unreached
Andrew D. Kerkhoff(San Francisco General Hospital), Adithya Cattamanchi(University of California, San Francisco), Monde Muyoyeta(Centre for Infectious Disease Research in Zambia), Claudia M. Denkinger(Heidelberg University), Devasahayam Jesudas Christopher, William Worodria(Mulago Hospital), Nora West(University of California, San Francisco), Grant Theron(South African Medical Research Council), David Branigan(Treatment Action Group), María del Mar Castro(Centro Internacional de Entrenamiento e Investigaciones Medicas), Nguyen Viet Nhung(VNU University of Science), Charles Yu(De La Salle Medical and Health Sciences Institute)
Cited by 18
Related Papers
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532